Merck & Co Inc
XETRA:6MK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
XETRA:6MK
Watchlist
Price: 93.5 EUR -1.48%
Market Cap: 236.8B EUR

Intrinsic Value

The intrinsic value of one 6MK stock under the Base Case scenario is hidden EUR. Compared to the current market price of 93.5 EUR, Merck & Co Inc is hidden .

6MK Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Merck & Co Inc

Intrinsic Value History
Dive into the past to invest in the future

6MK looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 6MK is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about 6MK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 6MK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Merck & Co Inc.

Explain Valuation
Compare 6MK to
Custom
Choose any stock to compare

Fundamental Analysis

6MK Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

6MK Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heavily reliant on Keytruda’s continued success, Merck faces heightened risk if competitors launch effective immuno-oncology therapies or if pricing pressures intensify following patent expiration.

Bull Theses

Keytruda’s dominant position in the immuno-oncology market and ongoing label expansions are poised to drive strong, sustained revenue and strengthen Merck’s leadership in cancer treatments.

Show More Less
How do you feel about MRK?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Merck & Co Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

6MK Price Targets Summary
Merck & Co Inc

Wall Street analysts forecast 6MK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 6MK is 97.86 EUR with a low forecast of 72.09 EUR and a high forecast of 121.9 EUR.

Lowest
Price Target
72.09 EUR
23% Downside
Average
Price Target
97.86 EUR
5% Upside
Highest
Price Target
121.9 EUR
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MRK is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MRK Insider Trading
Buy and sell transactions by insiders

6MK News

Other Videos
What is the Intrinsic Value of one 6MK stock?

The intrinsic value of one 6MK stock under the Base Case scenario is hidden EUR.

Is 6MK stock undervalued or overvalued?

Compared to the current market price of 93.5 EUR, Merck & Co Inc is hidden .

Back to Top